Professor
Plants for Human Health Institute, North Carolina State University, North Carolina Research Campus
Kannapolis, North Carolina, United States
Dr. Iorizzo is a Professor, distinguished Faculty Scholar at NC State University and Associated Director at the Plants for Human Health Institute, North Carolina State University. His research program focus on comparative structural genomics and genetics for traits associated with enhanced quality characteristics including bioactives. Crop of interest of his program include carrot, blueberry, cranberry, spinach, pineapple, banana. Since 2010, his research in has significantly contributed to establish the largest set of omics tools for these crop and elucidated the genetic mechanism controlling nutrients, bioactive (e.g. carotenoids, anthocyanins) and other primary metabolites (sugars, organic acids). Through interdisciplinary collaborative research, he initiated efforts to understand the relationship between genetics and nutrigenomic properties of plant bioactive like anthocyanin. This work is opening a new field of research that can contribute to close the gap between crop breeding and genetics and their nutritional value. He is the director and co-project director of large multidisciplinary and international projects in blueberry, cranberry and carrot that are contributing to advance application of molecular breeding in these crops. His is a very active scientific writer, he has authored and co-authored 140 referred publications, and >351 non-referred publications and oral presentations.
Prior to joining NCSU, Dr. Iorizzo was a Research Scientist at University of Wisconsin-Madison. Before this, he was PhD student at the University of Naples Federico II and visiting scientist at the University of Minnesota.
Friday, July 24, 2026
2:00 PM - 5:50 PM ET
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Carotenoid Biosynthesis and Bioaccessibility: New Insights and Future Opportunities
Friday, July 24, 2026
3:50 PM - 4:15 PM ET
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.